ARCHIVES

UC Davis Is U.S. Site For Trial Of Exemestane For Breast Ca.

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

CMS, FDA Developing Process For Concurrent Therapy ApprovalsAACI To Honor Mary-Claire King, Sen. Sherrod Brown

October 1, 2010

Novel Compounds Alone Or Combined With Chemo Tested In Blood Cancers

January 26, 2007

Pryor Calls For Price Regulation Of Drugs In Health Reform

February 12, 1993

Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds

October 31, 2003

Markup Of Cancer Act Renewal Set For Mid-October

September 21, 1979

Progress Reported On Zinder Recommendations for Virus Program

July 4, 1975